UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000038100 |
|---|---|
| Receipt number | R000043428 |
| Scientific Title | Safety and efficacy in the initiation of IDegLira for the outpatient with type 2 diabetes |
| Date of disclosure of the study information | 2019/10/01 |
| Last modified on | 2022/07/06 09:18:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/09/25 20:15:53 | ||
| 2 | Update | 2020/03/28 13:53:33 | Email Email1 |
|
| 3 | Update | 2020/03/28 13:56:54 | Anticipated trial start date Last follow-up date |
|
| 4 | Update | 2020/07/04 15:56:30 | Last follow-up date |
|
| 5 | Update | 2020/07/05 12:55:55 | Recruitment status |
|
| 6 | Update | 2020/07/05 12:58:36 | Last follow-up date |
|
| 7 | Update | 2020/07/22 13:10:37 | Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 8 | Update | 2020/07/30 23:41:17 | Results Results |
|
| 9 | Update | 2022/07/05 17:42:48 | URL releasing protocol URL related to results and publications |
|
| 10 | Update | 2022/07/05 19:02:07 | Participant flow |
|
| 11 | Update | 2022/07/06 09:11:03 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 12 | Update | 2022/07/06 09:18:28 | Recruitment status |
